Teh Seng Pharmaceutical Mfg. Co., Ltd. 3rd Plant – FDA 483, Aug 4, 2023
An FDA inspection of Teh Seng Pharmaceutical Mfg. Co., Ltd. in Tainan City, Taiwan, revealed two significant observations related to quality control. The firm failed to ensure laboratory controls included scientifically sound standards, specifically regarding the qualification of working standards against primary reference standards. Additionally, investigations into unexplained discrepancies were found to be inadequate, with CAPAs lacking proper documentation for root causes, impact evaluations, and effectiveness processes.
- Inspection date
- August 4, 2023
- Product type
- drugs
ID · 10f46aeb-ff3e-43c9-ae4f-45207e712511
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.